The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Canihelmin plus 50 mg/144 mg/150 mg tablets for dogs

50/144/150 mg/tablet Tablet

GENERA IncVPA10405/001/001

Main Information

Trade NameCanihelmin plus 50 mg/144 mg/150 mg tablets for dogs
Active SubstancesPraziquantel
Febantel
Pyrantel embonate
Strength50/144/150 mg/tablet
Dosage FormTablet
Licence HolderGENERA Inc
Licence NumberVPA10405/001/001

Group Information

ATC CodeQP52AA51 praziquantel, combinations
Therapeutic ClassEndoparasiticide
SpeciesDogs

Status

Authorised/WithdrawnAuthorised
Licence Issued26/08/2016
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back